ReviewCancers2021

Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer.

Naoki Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.